Of action. HfO2-NP+RT is currently evaluated in six other clinical trials including head and neck,
Of action. HfO2-NP+RT is currently evaluated in six other clinical trials including head and neck, prostate, liver and rectum cancers. Moreover, preclinical mGluR3 custom synthesis research have demonstrated that HfO2-NP+RT…